Panel launches new MDLs for Abbott baby formula, Merck”s Gardasil

Friday, 5 August 2022, 21:34:58
A federal judicial panel has created new federal mass tort dockets to handle claims that babies sickened by formula from an Abbott Laboratories plant closed earlier this year over safety concerns, and that Merck & Co Inc”s Gardasil vaccine against human papillomavirus caused serious autoimmune conditions.
— Reuters

Abbott Laboratories: A Lesser Johnson & Johnson? (NYSE:ABT)

Friday, 5 August 2022, 00:12:46
Similar to JNJ, ABT is a broadly diversified medical device and healthcare company. It has received much attention for its strong performance during the pandemic.
— Seeking Alpha

Why Is Senseonics (SENS) Stock Heating Up Today?

Thursday, 4 August 2022, 15:58:56
Senseonics (NYSEAMERICAN: SENS ) stock jumped by over 50% after it announced its Eversense implantable glucose monitor was approved for coverage by Elevance Health (NYSE: ELV ), formerly known as Anthem. Senseonics had revenue of just $2.5 million in the first quarter. SENS stock’s latest move still leaves the market cap short of $1 billion. Hidden in the first-quarter numbers, however, was growth in U.S. sales, which could now climb rapidly. Senseonomics’ Eversense is offered in two versions: one that can run for 3 months and one that operates for 6 months . It competes with Abbott Laboratories’ (NYSE: ABT ) Freestyle Libre , which lasts 14 days . The Big Opportunity in Glucose Monitoring The market for glucose monitors was worth $11.7 billion in 2021 and is growing at over 7% per year. It includes devices that use testing strips, lancets, and continuous meters like the Eversense. I wrote about Senseonomics for Investorplace last December, when its stock price was at $2.67 and its market cap over $1 billion .
— InvestorPlace

Blood Screening Market Estimated to Experience a Hike in Growth by 2021-2031 | Grifols , F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc., bioMérieux

Wednesday, 3 August 2022, 08:32:46
The blood screening market size was USD 2.8 billion in 2021 and it is anticipated to reach USD 5.5 billion in 2031, growing at a CAGR of 6.9% from 2022-2031. Global Blood Screening Market report from Global Insight Services is the
— OpenPR

If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today

Sunday, 31 July 2022, 13:55:00
The real question may be, has Abbott been a better buy than AbbVie since the spinoff?
— The Motley Fool